Kohei Kaku

69PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Jul 20, 2026
Durability and Safety of Imeglimin as an Add-On to DPP-4 Inhibitors in Japanese Type 2 Diabetes: The 104-Week FAMILIAR Trial.

|May 17, 2026
Indicators for predicting continuous insulin infusion therapy-related hypokalemia: multicenter retrospective cohort study.

|Dec 08, 2025
Predictors of glycemic control with imeglimin for type 2 diabetes: Results of machine learning analyses using clinical trial data.

Katsuhiko Hagi, Kazumasa Yoshida, Hirotaka Watada

|Nov 25, 2025
Correlation between diabetes complications severity index and actual complication severity and diabetic medication in Japanese patients with type 2 diabetes mellitus.

Yuichiro Iwamoto, Hideyuki Iwamoto, Tomohiko Kimura

|Oct 31, 2025
A decade of SGLT2 inhibitors: Lessons learned and the road ahead in type 2 diabetes.

Tomohiko Kimura, Kohei Kaku

|Oct 02, 2025
Molecular mechanism for pancreatic β-cell dysfunction and atherosclerosis and its therapeutic application: Importance of translational research bridging clinical practice and basic research.

Hideaki Kaneto, Tomohiko Kimura, Junpei Sanada

Pageof 12

Frequent Collaborators

15 joint publications

Masashi Shimoda

15 joint publications

Tomohiko Kimura

11 joint publications

Hideaki Kaneto

9 joint publications

Hideki Suganami